HUM EBITDA Growth
Humana · EBITDA Growth
HUM EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-15.47%period ending
HUM TTM EBITDA YoY % (-73.70% → -15.47%)
Year-over-year change
High-resolution chart · PNG
HUM ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -15.4707% | |
| -26.6529% | |
| -10.6605% | |
| -11.9636% | |
| -6.194% | |
| -7.2979% | |
| -31.1839% | |
| -32.4568% | |
| -27.5274% | |
| -19.7819% | |
| -1.6632% | |
| 8.9502% | |
| 5.9969% | |
| 11.8793% | |
| 7.8959% | |
| 19.0441% | |
| 23.3568% | |
| -21.3468% | |
| -20.0072% | |
| -38.9699% | |
| -27.2326% | |
| 39.1101% | |
| 29.9977% | |
| 59.4091% | |
| 37.7583% | |
| 23.3391% | |
| 70.4573% | |
| 68.5306% | |
| 85.7724% | |
| 37.1632% | |
| -40.9901% | |
| -27.4074% | |
| -41.7368% | |
| -27.8651% | |
| 75.8976% | |
| 7.2109% | |
| 42.4822% | |
| 23.9901% | |
| -20.9204% | |
| -0.2219% | |
| -12.6719% | |
| -2.2515% | |
| 9.0004% | |
| 30.5877% | |
| 25.0614% | |
| 17.933% | |
| 13.0277% | |
| -13.5908% | |
| -14.2556% | |
| -10.231% | |
| 5.65% | |
| 18.3311% | |
| 19.47% | |
| 7.3258% | |
| -11.0645% | |
| -5.3409% | |
| -1.0505% | |
| 14.8913% | |
| 24.9975% | |
| 6.4476% | |
| 10.0234% | |
| 6.0523% | |
| 8.1545% | |
| 29.4975% | |
| 35.8812% | |
| 40.8233% | |
| 51.3643% | |
| 31.9786% | |
| 3.9371% | |
| -5.3198% | |
| -16.1701% | |
| -2.9126% | |
| 31.3269% | |
| 62.1622% | |
| 58.4465% | |
| 72.2% | |
| 88.1213% | |
| 60.5594% | |
| 69.1856% | |
| 53.3143% | |
| 6.4483% | |
| 4.0235% | |
| 3.3729% | |
| -8.4945% | |
| 8.1626% | |
| 9.6457% | |
| 13.9% | |
| 50.0978% | |
| 44.9376% | |
| 54.4731% | |
| 40.5115% | |
| -9.0009% | |
| -8.4993% | |
| -4.0827% | |
| 16.3879% | |
| 61.3005% | |
| 90.0762% | |
| 49.0656% | |
| 27.747% | |
| 71.3052% |